Wednesday at 2pm(PT), July 1, 2020
Learn from MSK experts on how to masterfully handle every step of a MSK case
AI for early breast cancer detection
Redfining Healthcare through AI-Enhanced Mammography Interpretation.
Artificial Intelligence for Early Breast Cancer Detection.
Early detection of breast cancer is important for better outcomes and treatment options. SecondReadAI™ uses artificial intelligence (AI) to perform a detailed analysis of your mammogram and alert the interpreting physician of any suspicious areas that may be too small for the human eye to identify.
See the SecondReadAI™ difference
Radiologist review: No cancer detected
SecondReadAI™ review: Suspicion of breast cancer detected (indicated by yellow highlighted area)
HOW IT WORKS
Leveraging the power of AI (Artificial Intelligence), SecondReadAI™, a computer-based artificial intelligence tool, reviews and analyzes your breasts in a way that a human cannot. It looks at the images pixel by pixel and can detect suspicious breast tissue that might be obscured by dense tissue or that is too small for the human eye to detect. It is proven in clinical studies to help radiologists increase early-stage cancer detection by as much as 15%* and confidently reduce the number of unnecessary callbacks.
● 40% of breast cancer patients can be diagnosed earlier**
● The five-year survival rate of cancer detected early (Stage 1,2) is 96%***
Think of it as a second set of eyes using the best medical technology to provide a more detailed analysis of your mammogram. You will have peace of mind that every detail is analyzed.
TAKE CARE OF YOURSELF
Consider SecondReadAI™ as a second set of eyes to review the tiniest details of your mammogram and provide you with the peace of mind you deserve. Catching potential problems early is key to staying healthy and staying ahead of breast cancer. Give this gift to yourself…because YOU’RE WORTH IT.
EXPERT INSIGHTS ON SecondReadAI™
SecondReadAI™ FAQs
This AI software cannot guarantee breast cancer detection with 100% accuracy.
SecondReadAI™ is a trademark of Lunit Inc.
*Lunit INSIGHT MMG research study: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(20)30003-0/fulltext
**Lunit INSIGHT MMG research study: http://www.breastsurgeonsweb.com/noticias/ajcc-breast-cancer-staging-8-edition.html
***Lunit INSIGHT MMG research study: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(20)30003-0/fulltext